Animal vaccine agreement

Looking to grab a piece of the expanding market for animal medicines, AVANT Immunotherapeutics
| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
NEEDHAM, Mass.—Looking to grab a piece of the expanding market for animal medicines, AVANT Immunotherapeutics announced the signing of a collaborative R&D agreement with veterinarian drug industry leader Pfizer to develop animal vaccines. The collaboration will rely on AVANT's proprietary vaccine platform and will focus on prophylactic and therapeutic treatments for respiratory and enteric diseases.
 
"We are very pleased to extend our collaboration with Pfizer to leverage the value of AVANT's vaccine technology in a significant market opportunity outside AVANT's own focus on human health care," said Dr. Una S. Ryan, AVANT president and CEO.
 
Given the increase in the global incidence of pathogens such as bovine spongiform encephalopathy and bird flu, world interest in veterinary medicines has increased, and according to an October 2004 report, the market for veterinary vaccines alone will reach $3 billion by 2008.

About the Author

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Close-up illustration of clustered, irregularly shaped 3D cell structures resembling organoids, displayed in a blue-toned background.
Machine learning-powered image analysis makes it possible to automatically and reliably quantify complex 3D cell structures.
Illustration of a glowing human brain with interconnected neural networks and bright data points, set against a dark, digital background.
Take a closer look at modern techniques that reveal when, where, and how neurons communicate in real time.
Gloved hand holding a petri dish containing red liquid culture medium against a light blue background.
As global regulations shift toward animal-free testing, how can researchers develop more biologically relevant in vitro models to advance drug discovery?
Drug Discovery News June 2025 Issue
Latest IssueVolume 21 • Issue 2 • June 2025

June 2025

June 2025 Issue

Explore this issue